Alteogen Inc
KOSDAQ:196170

Watchlist Manager
Alteogen Inc Logo
Alteogen Inc
KOSDAQ:196170
Watchlist
Price: 356 000 KRW 0.99% Market Closed
Market Cap: 19T KRW

P/FCFE
Price to FCFE

426.3
Current
-32.3
Median
25.4
Industry
Higher than median
Higher than industry value

Price to Free Cash Flow To Equity (P/FCFE) ratio is a valuation multiple that compares a company’s market capitalization to the amount of free cash flow available for equity shareholders. This metric is very similar to the P/OCF but is considered a more exact measure, owing to the fact that it uses free cash flow, which subtracts capital expenditures (CapEx) from a company's operating cash flow.

P/FCFE
426.3
=
Market Cap
19T KRW
/
FCFE
44.5B KRW
Market Cap P/FCFE
KR
Alteogen Inc
KOSDAQ:196170
19T KRW 426.3
FR
Pharnext SCA
OTC:PNEXF
6T USD -3 104 325.2
US
Abbvie Inc
NYSE:ABBV
362.4B USD 16.5
US
Amgen Inc
NASDAQ:AMGN
164.8B USD 51.4
US
Gilead Sciences Inc
NASDAQ:GILD
139.3B USD 12.5
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
126.6B USD -133.8
US
Epizyme Inc
F:EPE
94.1B EUR -442
AU
CSL Ltd
ASX:CSL
120.7B AUD 53.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
69.9B USD 20
US
Seagen Inc
F:SGT
39.3B EUR -60.8
NL
argenx SE
XBRU:ARGX
32.3B EUR -105.2

P/FCFE Forward Multiples

Forward P/FCFE multiple is a version of the P/FCFE ratio that uses forecasted free cash flow to equity for the P/FCFE calculation. 1-Year, 2-Years, and 3-Years forwards use free cash flow to equity forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/FCFE
N/A
2-Years Forward
P/FCFE
N/A
3-Years Forward
P/FCFE
N/A